X

Xencor
D

XNCR

24.210
USD
0.05
(0.21%)
Market Open
Volume
14,495
EPS
-3
Div Yield
-
P/E
-8
Market Cap
1,694,264,946
Related Instruments
    AMGN
    AMGN
    -2.07
    (-0.79%)
    261.37 USD
    BIIB
    BIIB
    1.670
    (1.14%)
    148.260 USD
    B
    BLUE
    -0.74000
    (-8.72%)
    7.75000 USD
    B
    BMRN
    0.200
    (0.30%)
    65.880 USD
    C
    CLDT
    -0.11000
    (-1.20%)
    9.06000 USD
    GILD
    GILD
    0.100
    (0.11%)
    92.670 USD
    ILMN
    ILMN
    -2.040
    (-1.50%)
    133.890 USD
    I
    INCY
    0.390
    (0.57%)
    69.300 USD
    REGN
    REGN
    8.80
    (1.25%)
    711.40 USD
    T
    TGTX
    0.220
    (0.68%)
    32.420 USD
    More
News

Title: Xencor

Sector: Healthcare
Industry: Biotechnology
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.